Enzo Biochem - 41 Year Stock Price History | ENZ

Historical daily share price chart and data for Enzo Biochem since 1980 adjusted for splits. The latest closing stock price for Enzo Biochem as of October 22, 2021 is 3.31.
  • The all-time high Enzo Biochem stock closing price was 122.00 on January 21, 2000.
  • The Enzo Biochem 52-week high stock price is 4.85, which is 46.5% above the current share price.
  • The Enzo Biochem 52-week low stock price is 1.80, which is 45.6% below the current share price.
  • The average Enzo Biochem stock price for the last 52 weeks is 3.03.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Enzo Biochem Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2021 3.2301 2.6600 4.0900 2.6100 3.3100 31.35%
2020 2.3941 2.7600 3.8700 1.8200 2.5200 -4.18%
2019 3.3306 2.8000 4.3100 2.5400 2.6300 -5.40%
2018 5.2278 8.2500 8.3600 2.4600 2.7800 -65.89%
2017 9.2622 7.1400 11.7900 6.4000 8.1500 17.44%
2016 5.5990 4.6900 7.4800 4.0600 6.9400 54.22%
2015 3.3382 4.4500 4.9500 2.4300 4.5000 1.35%
2014 4.4767 2.9200 6.0800 2.6900 4.4400 52.05%
2013 2.4717 2.7500 3.1000 1.9400 2.9200 8.15%
2012 2.2276 2.3700 3.0500 1.4600 2.7000 20.54%
2011 3.5622 5.5000 5.7900 1.9900 2.2400 -57.58%
2010 4.8886 5.6700 6.6700 3.3700 5.2800 -1.86%
2009 5.0182 5.1000 7.6600 2.9000 5.3800 10.02%
2008 9.3999 12.9800 14.8300 3.5000 4.8900 -61.62%
2007 14.3258 14.5700 18.6500 10.0500 12.7400 -10.72%
2006 12.8201 12.5500 16.0000 9.3000 14.2700 14.90%
2005 15.4169 19.3000 19.3000 12.4200 12.4200 -36.21%
2004 16.2483 17.9500 20.4500 11.7100 19.4700 8.71%
2003 17.7666 14.6000 28.4300 11.5200 17.9100 27.93%
2002 16.6054 24.5500 25.7200 11.6500 14.0000 -40.43%
2001 22.9783 21.8100 34.9800 13.9500 23.5000 -5.55%
2000 53.9979 44.0000 122.0000 20.4400 24.8800 -45.91%
1999 17.7067 10.3800 46.8800 8.1250 46.0000 346.17%
1998 12.2603 14.6300 16.2500 6.5000 10.3100 -29.53%
1997 15.9713 18.5000 20.6300 13.0000 14.6300 -19.26%
1996 17.3435 19.7500 21.1300 14.2500 18.1200 -5.87%
1995 14.2192 11.3800 23.7500 9.6250 19.2500 72.96%
1994 12.4075 16.0000 19.3800 7.7500 11.1300 -29.91%
1993 10.8082 7.7500 19.8800 6.5000 15.8800 115.32%
1992 5.0900 3.3700 7.5000 3.2500 7.3750 96.67%
1991 1.6484 1.8800 7.8800 0.5000 3.7500 76.06%
1990 3.0223 3.8700 4.5000 1.7500 2.1300 -41.16%
1989 3.6294 3.1300 4.8700 2.6300 3.6200 11.38%
1988 3.9506 4.0000 4.8700 2.5000 3.2500 -13.33%
1987 8.4392 8.7500 12.1200 3.2500 3.7500 -57.14%
1986 12.7321 12.1200 18.7500 8.3800 8.7500 -29.26%
1985 14.1660 15.2500 21.0000 10.3700 12.3700 -17.53%
1984 16.3823 25.6200 26.2500 12.2500 15.0000 -39.69%
1983 24.7116 16.2467 33.5000 16.2467 24.8700 40.77%
1982 10.3396 10.5000 17.6667 5.5000 17.6667 66.98%
1981 9.2933 3.6233 15.0800 3.4567 10.5800 192.00%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.159B $0.118B
Enzo Biochem, Inc. develops, manufactures and markets health care products based on molecular biology and genetic engineering techniques, and also provides diagnostic services to the medical community. The business activities of the company are performed by one of the company's three wholly-owned subsidiaries--Enzo Diagnostics, Inc., Enzo Therapeutics, Inc., and Enzo Clinical Labs, Inc. The primary focus of the company's research is the development of products based on two technology platforms -- genetic modulation and immune modulation.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $128.460B 8.55
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.211B 20.68
Biohaven Pharmaceutical Holding (BHVN) United States $8.952B 0.00
Emergent Biosolutions (EBS) United States $2.717B 6.55
Arcus Biosciences (RCUS) United States $2.502B 0.00
Myovant Sciences (MYOV) United Kingdom $1.906B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.820B 0.00
Zymeworks (ZYME) Canada $1.088B 0.00
Ambrx Biopharma (AMAM) United States $0.513B 0.00
SQZ Biotechnologies (SQZ) United States $0.343B 0.00